Patients For Affordable Drugs

Patients For Affordable Drugs is the only independent national patient org fighting to achieve policy changes to lower the price of #prescriptiondrugs.

[Patients For Affordable Drugs @P4AD_]

P4AD Town Hall https://t.co/hHWAgUpJOb

[Patients For Affordable Drugs @P4AD_]

Today's unanimous Supreme Court ruling protects a key pathway for lower-cost generic drugs to reach patients sooner.

By preserving "skinny labeling," the Court affirmed that generic manufacturers can bring more affordable versions of medicines to market for off-patent uses without waiting for every patent claim to expire.

Generic competition is one of the most effective ways to lower prescription drug prices, reducing costs by 39% with one competitor and by as much as 95% when multiple generics enter the market. This decision is a win for competition, affordability, and patients.

[Patients For Affordable Drugs @P4AD_]

Patient advocate Amelia is right, no one needs to suffer alone. If you struggle with the high cost of prescription drugs, share your story with P4AD and join our community of over 40,000 today: https://t.co/JTkvYQdyEQ

[Patients For Affordable Drugs @P4AD_]

🗓️ Mark your calendars for P4AD’s June 2026 Town Hall Series beginning TOMORROW (Thursday) at 4 P.M. ET!🗓️

Throughout the month of June, P4AD will be hosting a weekly series featuring members of our senior staff sharing updates from across our work and answering questions from our community!

Episodes will stream live every Thursday at 4 P.M. ET across YouTube, LinkedIn, Facebook, and X.

RSVP to receive event reminders and to submit questions for our speakers: https://t.co/yeajxIY2zB

[Patients For Affordable Drugs @P4AD_]

👏 Patients are finally able to access the lifesaving medication they need at a price they can afford thanks to the 2022 prescription drug law's $35 cap on insulin!

[Patients For Affordable Drugs @P4AD_]

🗓️ Mark your calendars for P4AD’s June 2026 Town Hall Series beginning this Thursday at 4 P.M. ET!🗓️

Throughout the month of June, P4AD will be hosting a weekly series featuring members of our senior staff sharing updates from across our work and answering questions from our community!

Episodes will stream live every Thursday at 4 P.M. ET across YouTube, LinkedIn, Facebook, and X.

RSVP to receive event reminders and to submit questions for our speakers: https://t.co/yeajxIY2zB

[Patients For Affordable Drugs @P4AD_]

🗣️ P4AD patient advocates like Emily know the powerful impact of sharing their struggles with high drug costs with lawmakers firsthand. Have you been affected by high drug prices? Get involved with advocacy by sharing your story today: https://t.co/JTkvYQdyEQ

[Patients For Affordable Drugs @P4AD_]

Cystic fibrosis families know that the cost of medication can be the difference between life and death for patients with CF. No parent should have to live in fear that their child won't be able to access the prescription drugs they need to survive. Visit https://t.co/lLoXKLYI2e and learn how advocates like Don are sharing their experiences with high drug costs to create policy change and lower drug prices.

[Patients For Affordable Drugs @P4AD_]

Use your voice to help change policy! Share your story with P4AD: https://t.co/JTkvYQdyEQ

¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4AD: https://t.co/SvR4rZE1Ic

[Patients For Affordable Drugs @P4AD_]

Our mobile billboard is out and about in Washington D.C.! 🇺🇸 The Supreme Court’s decision to decline pharma’s arguments against Medicare Negotiation is a win for patients. If you see the truck, share your pictures with us!

[Patients For Affordable Drugs @P4AD_]

Today’s decision is a big win for patients in the fight against the pharmaceutical industry’s greed!

The Supreme Court declined petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program – letting lower court rulings stand that will let the program move forward and continue delivering relief to patients.

It’s US vs. pharma, and today, patients won!

[Patients For Affordable Drugs @P4AD_]

🥳 A win for patients! 🥳

This morning, the Supreme Court declined petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, allowing the program to continue delivering lower drug prices for patients across the nation.

Medicare negotiation was a huge win for patients and taxpayers and, as a result, people on Medicare now have access to innovative, life-saving treatments at lower costs.

Learn more about Big Pharma's efforts to undermine Medicare negotiation and how P4AD is working to protect it at https://t.co/v2QsNbhNeT

[Patients For Affordable Drugs @P4AD_]

💸 Big Pharma profits while patients struggle to afford the prescription drugs they need. Learn how our growing community of patients and allies are fighting back at https://t.co/J9HDfxkGmd.

[Patients For Affordable Drugs @P4AD_]

Fundada por David Mitchell, un paciente que vive con cáncer incurable, Patients For Affordable Drugs trabaja para empoderar y movilizar a pacientes y aliados, exigir responsabilidad a quienes tienen poder y luchar por políticas que transformen el sistema y hagan que los medicamentos recetados sean accesibles para todas las personas en Estados Unidos. Conoce más sobre nuestro trabajo y la lucha por precios justos en los medicamentos en https://t.co/CkcBKN2dTp.

Founded by a patient living with incurable cancer, David Mitchell, Patients For Affordable Drugs strives to empower and mobilize patients and allies, hold accountable those in power, and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. Learn more about our work and the fight for prescription drugs at accessible prices at https://t.co/lLoXKLYI2e.

🎥: @tiemponews @elplanetaboston

[Patients For Affordable Drugs @P4AD_]

We’ve reached a new milestone: 40,000 vetted patient stories now on our map 🇺🇸 While we are proud to be fighting alongside thousands of patients, this is a reminder of the urgency needed to address the crisis of high drug prices.

40,000 is not just a number. This represents real stories of patients from every state and every congressional district. If you or someone you know is struggling with the high cost of prescription drugs, share your story today.

Join us in urging Congress to make sure that every American can get the medications they need at prices they can afford.

https://t.co/qEWwR822ir

[Patients For Affordable Drugs @P4AD_]

👏 Patients are finally able to access the lifesaving medication they need at a price they can afford thanks to the 2022 prescription drug law's $35 cap on insulin!

[Patients For Affordable Drugs @P4AD_]

Patient adovcate Amelia is right, no one needs to suffer alone. If you struggle with the high cost of prescription drugs, share your story with P4AD. You can join our community of over 40,000 who are ready to shape policies in favor of patients. Share your story today: https://t.co/qEWwR822ir

[Patients For Affordable Drugs @P4AD_]

P4AD has reached 40,000 vetted patient stories. From every state. And every Congressional district.

This isn’t just a milestone – it’s the sobering reality caused by a system that’s failing patients across the country.

Behind each of these stories is someone forced to make impossible choices just to afford the medications they or a loved one needs.

When this many people are speaking out and demanding change, lawmakers can’t afford to ignore it.

[Patients For Affordable Drugs @P4AD_]

No one should have to drain their savings and miss out on family time to afford their medications. Unfortunately, this was the reality that P4AD Patient Advocate, Bob Parant lived before Medicare negotiation.

But now, thanks to the 2022 prescription drug law and Medicare's ability to negotiate prices for the most costly and widely used prescription drugs, his drug, Entresto's price has been slashed by 62%!

To learn more about the relief that Medicare negotiation is delivering to patients visit: https://t.co/ivhl4OyqqX

[Patients For Affordable Drugs @P4AD_]

Regeneron has become the latest pharmaceutical company to enter a most-favored-nation (MFN) pricing agreement with the Trump administration. The announcement came alongside the FDA’s expedited approval of Otarmeni. A gene therapy to treat a rare form of genetic deafness, which affects approximately 50 Americans born each year.